RRP8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.244570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.339410E-01
Normal-vs-Stage2
1.370390E-01
Normal-vs-Stage3
2.670800E-01
Normal-vs-Stage4
5.605400E-01
Stage1-vs-Stage2
4.759600E-01
Stage1-vs-Stage3
7.579400E-01
Stage1-vs-Stage4
1.427240E-01
Stage2-vs-Stage3
2.730200E-01
Stage2-vs-Stage4
2.875800E-01
Stage3-vs-Stage4
3.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.177950E-01
Normal-vs-AfricanAmerican
5.697900E-02
Normal-vs-Asian
5.151200E-01
Caucasian-vs-AfricanAmerican
7.391200E-01
Caucasian-vs-Asian
1.646640E-01
AfricanAmerican-vs-Asian
2.494400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.358620E-01
Normal-vs-Female
1.187030E-01
Male-vs-Female
5.425200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.169400E-01
Normal-vs-Age(41-60Yrs)
1.782430E-01
Normal-vs-Age(61-80Yrs)
9.470300E-02
Normal-vs-Age(81-100Yrs)
3.630800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.247200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.985400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.413800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.016990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.325400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.892770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.037400E-01
Normal-vs-Daily Drinker
1.372620E-01
Normal-vs-Weekly Drinker
2.831800E-01
Normal-vs-Occasional Drinker
2.131600E-01
Normal-vs-Social Drinker
1.299160E-01
Non Drinker-vs-Daily Drinker
7.926400E-01
Non Drinker-vs-Weekly Drinker
7.444000E-01
Non Drinker-vs-Occasional Drinker
6.452200E-01
Non Drinker-vs-Social Drinker
8.782400E-01
Daily Drinker-vs-Weekly Drinker
5.804000E-01
Daily Drinker-vs-Occasional Drinker
4.673200E-01
Daily Drinker-vs-Social Drinker
6.788600E-01
Weekly Drinker-vs-Occasional Drinker
9.400800E-01
Weekly Drinker-vs-Social Drinker
8.478400E-01
Occasional Drinker-vs-Social Drinker
7.539200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.923800E-01
Normal-vs-Grade 2
9.575200E-01
Normal-vs-Grade 3
9.329600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.436160E-01
Grade 1-vs-Grade 3
4.263800E-01
Grade 1-vs-Grade 4
8.923800E-01
Grade 2-vs-Grade 3
4.962600E-01
Grade 2-vs-Grade 4
9.575200E-01
Grade 3-vs-Grade 4
9.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.395800E-01
Normal-vs-NonDiabetic
7.625700E-02
Diabetic-vs-NonDiabetic
7.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.146400E-01
Normal-vs-NoPancreatitis
8.376400E-02
Pancreatitis-vs-NoPancreatitis
2.766300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.715800E-01
Normal-vs-N1
9.374200E-02
N0-vs-N1
9.225700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.968400E-01
Normal-vs-TP53-NonMutant
2.144000E-01
TP53-Mutant-vs-TP53-NonMutant
2.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
